Enrollment begins in the FDA-authorized FINALE pivotal trial evaluating FemBloc, a first-of-its-kind non-surgical permanent birth control, following positive clinical data -- ATLANTA, March 10, 2026 ...

Enrollment begins in the FDA-authorized FINALE pivotal trial evaluating FemBloc, a first-of-its-kind non-surgical permanent birth control, following positive clinical data -- ATLANTA, March 10, 2026 ...

Evidence shows that birth control pills containing the hormones estrogen and progestin can increase the risk of different types of cancers and decrease the risk of others.  Since 1999, the World ...

Transform your life with expert guidance from Pt. Pawan Kaushik, one of India’s best scientific astrologers. Discover ...

The market conditions we face now are vastly different compared to those under which the AWP was conceived. Click here to ...

Study data from patients with relapsed or refractory gynecologic cancers signals the potential of LYMPHIR to augment immune checkpoint inhibitor efficacy Topline data ...

Ever feel like a productivity hack just doesn’t click? You’ve tried time-blocking apps, bullet journals, maybe even the infamous morning cold plunge — yet something still feels off. What if the secret ...

When a teen girl recently posted on TikTok about the “pros and cons of birth control,” almost 120,000 people hit the “like” button. Of the pros, the girl said her birth control made her period ...

Marketers say content creation and enhancement has been the AI-driven tactic that's been most effective for their organization, according to recent research from Ascend2. The report was based on data ...

A two-step approach pooled indication-specific response rates, then generated naïve odds ratios via random-effects models, reflecting limited head-to-head evidence across BTK inhibitors. Across ...

Introduction Running is a popular recreational activity worldwide, with women’s participation growing rapidly over the past decade. Compared with men, women runners are more likely to sustain a ...